This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, Y.
Right arrow Articles by Androphy, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, Y.
Right arrow Articles by Androphy, E. J.

 Previous Article  |  Next Article 

Journal of Virology, September 1999, p. 7297-7307, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Multiple Functions of Human Papillomavirus Type 16 E6 Contribute to the Immortalization of Mammary Epithelial Cells

Yun Liu,1 Jason J. Chen,1 Qingshen Gao,2 Sorab Dalal,3,dagger Yihui Hong,1 Claire P. Mansur,1 Vimla Band,2,4 and Elliot J. Androphy1,3,*

Department of Dermatology,1 Department of Radiation Oncology,2 Department of Molecular Biology and Microbiology,3 and Department of Biochemistry,4 New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111

Received 28 April 1999/Accepted 28 May 1999

The E6 proteins from cervical cancer-associated human papillomavirus (HPV) types such as HPV type 16 (HPV-16) induce proteolysis of the p53 tumor suppressor protein through interaction with E6-AP. We have previously shown that human mammary epithelial cells (MECs) immortalized by HPV-16 E6 display low levels of p53. HPV-16 E6 as well as other cancer-related papillomavirus E6 proteins also binds the cellular protein E6BP (ERC-55). To explore the potential functional significance of these interactions, we created and analyzed a series of E6 mutants for their ability to interact with E6-AP, p53, and E6BP in vitro. While there was a similar pattern of binding among these E6 targets, a subset of mutants differentiated E6-AP binding, p53 binding, and p53 degradation activities. These results demonstrated that E6 binding to E6-AP is not sufficient for binding to p53 and that E6 binding to p53 is not sufficient for inducing p53 degradation. The in vivo activity of these HPV-16 E6 mutants was tested in MECs. In agreement with the in vitro results, most of these p53 degradation-defective E6 mutants were unable to reduce the p53 level in early-passage MECs. Interestingly, several mutants that showed severely reduced ability for interacting with E6-AP, p53, and E6BP in vitro efficiently immortalized MECs. These immortalized cells exhibited low p53 levels at late passage. Furthermore, mutants defective for p53 degradation but able to immortalize MECs were also identified, and the immortal cells retained normal levels of p53 protein. These results imply that multiple functions of HPV-16 E6 contribute to MEC immortalization.

* Corresponding author. Mailing address: Department of Dermatology, Box 166, New England Medical Center, 750 Washington St., Boston, MA 02111. Phone: (617) 636-1493. Fax: (617) 636-6190. E-mail: eandroph{at}opal.tufts.edu.

dagger Present Address: Dana-Farber Cancer Institute, Boston, MA 02115.

Journal of Virology, September 1999, p. 7297-7307, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Zhao, X., Lu, L., Pokhriyal, N., Ma, H., Duan, L., Lin, S., Jafari, N., Band, H., Band, V. (2009). Overexpression of RhoA Induces Preneoplastic Transformation of Primary Mammary Epithelial Cells. Cancer Res. 69: 483-491 [Abstract] [Full Text]  
  • Lee, D. W., Anderson, M. E., Wu, S., Lee, J. H. (2008). Development of an Adenoviral Vaccine Against E6 and E7 Oncoproteins to Prevent Growth of Human Papillomavirus-Positive Cancer. Arch Otolaryngol Head Neck Surg 134: 1316-1323 [Abstract] [Full Text]  
  • Shai, A., Pitot, H. C., Lambert, P. F. (2008). p53 Loss Synergizes with Estrogen and Papillomaviral Oncogenes to Induce Cervical and Breast Cancers. Cancer Res. 68: 2622-2631 [Abstract] [Full Text]  
  • Shamanin, V. A., Sekaric, P., Androphy, E. J. (2008). hAda3 Degradation by Papillomavirus Type 16 E6 Correlates with Abrogation of the p14ARF-p53 Pathway and Efficient Immortalization of Human Mammary Epithelial Cells. J. Virol. 82: 3912-3920 [Abstract] [Full Text]  
  • Sekaric, P., Cherry, J. J., Androphy, E. J. (2008). Binding of Human Papillomavirus Type 16 E6 to E6AP Is Not Required for Activation of hTERT. J. Virol. 82: 71-76 [Abstract] [Full Text]  
  • Yokota, T., Bui, T., Liu, Y., Yi, M., Hunt, K. K., Keyomarsi, K. (2007). Differential Regulation of Elafin in Normal and Tumor-Derived Mammary Epithelial Cells Is Mediated by CCAAT/Enhancer Binding Protein. Cancer Res. 67: 11272-11283 [Abstract] [Full Text]  
  • Hebner, C., Beglin, M., Laimins, L. A. (2007). Human Papillomavirus E6 Proteins Mediate Resistance to Interferon-Induced Growth Arrest through Inhibition of p53 Acetylation. J. Virol. 81: 12740-12747 [Abstract] [Full Text]  
  • Liu, X., Disbrow, G. L., Yuan, H., Tomaic, V., Schlegel, R. (2007). Myc and Human Papillomavirus Type 16 E7 Genes Cooperate To Immortalize Human Keratinocytes. J. Virol. 81: 12689-12695 [Abstract] [Full Text]  
  • Topffer, S., Muller-Schiffmann, A., Matentzoglu, K., Scheffner, M., Steger, G. (2007). Protein tyrosine phosphatase H1 is a target of the E6 oncoprotein of high-risk genital human papillomaviruses. J. Gen. Virol. 88: 2956-2965 [Abstract] [Full Text]  
  • Storrs, C. H., Silverstein, S. J. (2007). PATJ, a Tight Junction-Associated PDZ Protein, Is a Novel Degradation Target of High-Risk Human Papillomavirus E6 and the Alternatively Spliced Isoform 18 E6. J. Virol. 81: 4080-4090 [Abstract] [Full Text]  
  • Liu, Y., Heilman, S. A., Illanes, D., Sluder, G., Chen, J. J. (2007). p53-Independent Abrogation of a Postmitotic Checkpoint Contributes to Human Papillomavirus E6-Induced Polyploidy. Cancer Res. 67: 2603-2610 [Abstract] [Full Text]  
  • Shai, A., Brake, T., Somoza, C., Lambert, P. F. (2007). The Human Papillomavirus E6 Oncogene Dysregulates the Cell Cycle and Contributes to Cervical Carcinogenesis through Two Independent Activities. Cancer Res. 67: 1626-1635 [Abstract] [Full Text]  
  • McGahren-Murray, M., Terry, N. H.A., Keyomarsi, K. (2006). The Differential Staurosporine-Mediated G1 Arrest in Normal versus Tumor Cells Is Dependent on the Retinoblastoma Protein. Cancer Res. 66: 9744-9753 [Abstract] [Full Text]  
  • Simonson, S. J.S., Difilippantonio, M. J., Lambert, P. F. (2005). Two Distinct Activities Contribute to Human Papillomavirus 16 E6's Oncogenic Potential. Cancer Res. 65: 8266-8273 [Abstract] [Full Text]  
  • Lagrange, M., Charbonnier, S., Orfanoudakis, G., Robinson, P., Zanier, K., Masson, M., Lutz, Y., Trave, G., Weiss, E., Deryckere, F. (2005). Binding of human papillomavirus 16 E6 to p53 and E6AP is impaired by monoclonal antibodies directed against the second zinc-binding domain of E6. J. Gen. Virol. 86: 1001-1007 [Abstract] [Full Text]  
  • Malanchi, I., Accardi, R., Diehl, F., Smet, A., Androphy, E., Hoheisel, J., Tommasino, M. (2004). Human Papillomavirus Type 16 E6 Promotes Retinoblastoma Protein Phosphorylation and Cell Cycle Progression. J. Virol. 78: 13769-13778 [Abstract] [Full Text]  
  • Lee, C., Laimins, L. A. (2004). Role of the PDZ Domain-Binding Motif of the Oncoprotein E6 in the Pathogenesis of Human Papillomavirus Type 31. J. Virol. 78: 12366-12377 [Abstract] [Full Text]  
  • Gewin, L., Myers, H., Kiyono, T., Galloway, D. A. (2004). Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev. 18: 2269-2282 [Abstract] [Full Text]  
  • Garner-Hamrick, P. A., Fostel, J. M., Chien, W.-M., Banerjee, N. S., Chow, L. T., Broker, T. R., Fisher, C. (2004). Global Effects of Human Papillomavirus Type 18 E6/E7 in an Organotypic Keratinocyte Culture System. J. Virol. 78: 9041-9050 [Abstract] [Full Text]  
  • Lu, Z., Hu, X., Li, Y., Zheng, L., Zhou, Y., Jiang, H., Ning, T., Basang, Z., Zhang, C., Ke, Y. (2004). Human Papillomavirus 16 E6 Oncoprotein Interferences with Insulin Signaling Pathway by Binding to Tuberin. J. Biol. Chem. 279: 35664-35670 [Abstract] [Full Text]  
  • Longworth, M. S., Laimins, L. A. (2004). Pathogenesis of Human Papillomaviruses in Differentiating Epithelia. Microbiol. Mol. Biol. Rev. 68: 362-372 [Abstract] [Full Text]  
  • McMurray, H. R., McCance, D. J. (2004). Degradation of p53, Not Telomerase Activation, by E6 Is Required for Bypass of Crisis and Immortalization by Human Papillomavirus Type 16 E6/E7. J. Virol. 78: 5698-5706 [Abstract] [Full Text]  
  • Chakrabarti, O., Veeraraghavalu, K., Tergaonkar, V., Liu, Y., Androphy, E. J., Stanley, M. A., Krishna, S. (2004). Human Papillomavirus Type 16 E6 Amino Acid 83 Variants Enhance E6-Mediated MAPK Signaling and Differentially Regulate Tumorigenesis by Notch Signaling and Oncogenic Ras. J. Virol. 78: 5934-5945 [Abstract] [Full Text]  
  • Oh, S. T., Longworth, M. S., Laimins, L. A. (2004). Roles of the E6 and E7 Proteins in the Life Cycle of Low-Risk Human Papillomavirus Type 11. J. Virol. 78: 2620-2626 [Abstract] [Full Text]  
  • Shamanin, V. A., Androphy, E. J. (2004). Immortalization of Human Mammary Epithelial Cells Is Associated with Inactivation of the p14ARF-p53 Pathway. Mol. Cell. Biol. 24: 2144-2152 [Abstract] [Full Text]  
  • Patel, D., Incassati, A., Wang, N., McCance, D. J. (2004). Human Papillomavirus Type 16 E6 and E7 Cause Polyploidy in Human Keratinocytes and Up-Regulation of G2-M-Phase Proteins. Cancer Res. 64: 1299-1306 [Abstract] [Full Text]  
  • Nguyen, M. M., Nguyen, M. L., Caruana, G., Bernstein, A., Lambert, P. F., Griep, A. E. (2003). Requirement of PDZ-Containing Proteins for Cell Cycle Regulation and Differentiation in the Mouse Lens Epithelium. Mol. Cell. Biol. 23: 8970-8981 [Abstract] [Full Text]  
  • Tao, M., Kruhlak, M., Xia, S., Androphy, E., Zheng, Z.-M. (2003). Signals That Dictate Nuclear Localization of Human Papillomavirus Type 16 Oncoprotein E6 in Living Cells. J. Virol. 77: 13232-13247 [Abstract] [Full Text]  
  • Riley, R. R., Duensing, S., Brake, T., Munger, K., Lambert, P. F., Arbeit, J. M. (2003). Dissection of Human Papillomavirus E6 and E7 Function in Transgenic Mouse Models of Cervical Carcinogenesis. Cancer Res. 63: 4862-4871 [Abstract] [Full Text]  
  • Nguyen, M. L., Nguyen, M. M., Lee, D., Griep, A. E., Lambert, P. F. (2003). The PDZ Ligand Domain of the Human Papillomavirus Type 16 E6 Protein Is Required for E6's Induction of Epithelial Hyperplasia In Vivo. J. Virol. 77: 6957-6964 [Abstract] [Full Text]  
  • Nguyen, M., Song, S., Liem, A., Androphy, E., Liu, Y., Lambert, P. F. (2002). A Mutant of Human Papillomavirus Type 16 E6 Deficient in Binding {alpha}-Helix Partners Displays Reduced Oncogenic Potential In Vivo. J. Virol. 76: 13039-13048 [Abstract] [Full Text]  
  • Park, R. B., Androphy, E. J. (2002). Genetic Analysis of High-Risk E6 in Episomal Maintenance of Human Papillomavirus Genomes in Primary Human Keratinocytes. J. Virol. 76: 11359-11364 [Abstract] [Full Text]  
  • Kumar, A., Zhao, Y., Meng, G., Zeng, M., Srinivasan, S., Delmolino, L. M., Gao, Q., Dimri, G., Weber, G. F., Wazer, D. E., Band, H., Band, V. (2002). Human Papillomavirus Oncoprotein E6 Inactivates the Transcriptional Coactivator Human ADA3. Mol. Cell. Biol. 22: 5801-5812 [Abstract] [Full Text]  
  • Gardiol, D., Galizzi, S., Banks, L. (2002). Mutational analysis of the discs large tumour suppressor identifies domains responsible for human papillomavirus type 18 E6-mediated degradation. J. Gen. Virol. 83: 283-289 [Abstract] [Full Text]  
  • Gewin, L., Galloway, D. A. (2001). E Box-Dependent Activation of Telomerase by Human Papillomavirus Type 16 E6 Does Not Require Induction of c-myc. J. Virol. 75: 7198-7201 [Abstract] [Full Text]  
  • Nees, M., Geoghegan, J. M., Hyman, T., Frank, S., Miller, L., Woodworth, C. D. (2001). Papillomavirus Type 16 Oncogenes Downregulate Expression of Interferon-Responsive Genes and Upregulate Proliferation-Associated and NF-{kappa}B-Responsive Genes in Cervical Keratinocytes. J. Virol. 75: 4283-4296 [Abstract] [Full Text]  
  • Gao, Q., Singh, L., Kumar, A., Srinivasan, S., Wazer, D. E., Band, V. (2001). Human Papillomavirus Type 16 E6-Induced Degradation of E6TP1 Correlates with Its Ability To Immortalize Human Mammary Epithelial Cells. J. Virol. 75: 4459-4466 [Abstract] [Full Text]  
  • Hengstermann, A., Linares, L. K., Ciechanover, A., Whitaker, N. J., Scheffner, M. (2001). Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. Proc. Natl. Acad. Sci. USA 10.1073/pnas.031470698v1 [Abstract] [Full Text]  
  • Gaitonde, S. V., Qi, W., Falsey, R. R., Sidell, N., Martinez, J. D. (2001). Morphologic Conversion of a Neuroblastoma-derived Cell Line by E6-mediated p53 Degradation. Cell Growth Differ. 12: 19-27 [Abstract] [Full Text]  
  • Goodwin, E. C., Yang, E., Lee, C.-J., Lee, H.-W., DiMaio, D., Hwang, E.-S. (2000). Rapid induction of senescence in human cervical carcinoma cells. Proc. Natl. Acad. Sci. USA 97: 10978-10983 [Abstract] [Full Text]  
  • Nees, M., Geoghegan, J. M., Munson, P., Prabhu, V., Liu, Y., Androphy, E., Woodworth, C. D. (2000). Human Papillomavirus Type 16 E6 and E7 Proteins Inhibit Differentiation-dependent Expression of Transforming Growth Factor-{beta}2 in Cervical Keratinocytes. Cancer Res. 60: 4289-4298 [Abstract] [Full Text]  
  • Kao, W. H., Beaudenon, S. L., Talis, A. L., Huibregtse, J. M., Howley, P. M. (2000). Human Papillomavirus Type 16 E6 Induces Self-Ubiquitination of the E6AP Ubiquitin-Protein Ligase. J. Virol. 74: 6408-6417 [Abstract] [Full Text]  
  • Nevels, M., Rubenwolf, S., Spruss, T., Wolf, H., Dobner, T. (2000). Two Distinct Activities Contribute to the Oncogenic Potential of the Adenovirus Type 5 E4orf6 Protein. J. Virol. 74: 5168-5181 [Abstract] [Full Text]  
  • Gao, Q., Kumar, A., Srinivasan, S., Singh, L., Mukai, H., Ono, Y., Wazer, D. E., Band, V. (2000). PKN Binds and Phosphorylates Human Papillomavirus E6 Oncoprotein. J. Biol. Chem. 275: 14824-14830 [Abstract] [Full Text]  
  • Stünkel, W., Huang, Z., Tan, S.-H., O'Connor, M. J., Bernard, H.-U. (2000). Nuclear Matrix Attachment Regions of Human Papillomavirus Type 16 Repress or Activate the E6 Promoter, Depending on the Physical State of the Viral DNA. J. Virol. 74: 2489-2501 [Abstract] [Full Text]  
  • Hengstermann, A., Linares, L. K., Ciechanover, A., Whitaker, N. J., Scheffner, M. (2001). Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. Proc. Natl. Acad. Sci. USA 98: 1218-1223 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»